Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 453.55 -8.59 (-1.86%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vertex Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 ... 52 53 Next > What Analysts Are Saying About Vertex Pharmaceuticals Stock October 01, 2024 Via Benzinga Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. September 26, 2024 Pfizer stock dipped Thursday after the company voluntarily pulled its sickle cell drug, Oxbryta, from the market following patient deaths. Via Investor's Business Daily Vertex Highlights First Oral Presentation of Phase 3 Clinical Data of the Vanza Triple and New Data on Long-Term Impact of TRIKAFTA® at the North American Cystic Fibrosis Conference September 26, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire If You Invested $100 In This Stock 15 Years Ago, You Would Have $1,200 Today September 25, 2024 Via Benzinga Demystifying Vertex Pharmaceuticals: Insights From 16 Analyst Reviews September 19, 2024 Via Benzinga Looking Into Vertex Pharmaceuticals's Recent Short Interest September 18, 2024 Via Benzinga Vertex Pharmaceuticals's Options Frenzy: What You Need to Know August 29, 2024 Via Benzinga The Best Biotech Stock to Invest $1,000 in Right Now September 22, 2024 Vertex Pharmaceuticals isn't an ordinary biotech stock. Via The Motley Fool Bull Market and Beyond: 2 Stocks Just Waiting to Soar September 21, 2024 Great companies have persisted even in a tumultuous market. Via The Motley Fool Prediction: These Could Be the Best-Performing Biotech Stocks Through 2030 September 18, 2024 These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond. Via The Motley Fool 3 Stocks to Buy and Hold Forever September 14, 2024 These stocks are built for the long run. Via The Motley Fool Prediction: These 3 Phenomenal Stocks Are Set to Soar September 14, 2024 These stocks are already solid winners in 2024. They should be able to keep the momentum going. Via The Motley Fool Time To Invest And Or Trade In Bio-Tech Stocks? September 13, 2024 Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help... Via Talk Markets Topics ETFs Looking Into Vertex Pharmaceuticals's Recent Short Interest August 27, 2024 Via Benzinga Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals August 23, 2024 Via Benzinga Biotech Breakout: Stocks for Your Watchlist September 12, 2024 The iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150. Via MarketBeat Topics ETFs Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 20 Years September 06, 2024 Via Benzinga 3 No-Brainer Stocks to Buy in September August 31, 2024 There's at least one key common denominator here: tremendous growth prospects. Via The Motley Fool 3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever August 30, 2024 These three have secure core businesses, plus multiple paths to grow. Via The Motley Fool 3 Reasons to Buy Vertex Pharmaceuticals Stock Like There's No Tomorrow August 30, 2024 Vertex should have a future full of bright tomorrows. Via The Motley Fool If You Invested $100 In This Stock 20 Years Ago, You Would Have $4,900 Today August 21, 2024 Via Benzinga Biotech And Life Science Sector Update Summer Of 2024 August 29, 2024 It’s the slowest week of the year, we are at the market top and most earnings reports are good. Via Talk Markets Jim Cramer: 'Hold On' To Builders FirstSource, 'Here's The Problem' With Viking Therapeutics August 29, 2024 Jim Cramer discusses Serve Robotics, Builders FirstSource, Vertex Pharmaceuticals and Viking Therapeutics on CNBC. Via Benzinga Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead August 23, 2024 Vertex Pharmaceuticals has a lot going for it. Via The Motley Fool Vertex to Participate in Upcoming September Investor Conferences August 22, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire Biotech Bull Market: 3 Ways To Play It August 20, 2024 Although we are in the later stages of this bull market a cut in interest rates by the Fed should help biotech as you have seen from the recent rally. Via Talk Markets Topics Economy Exposures Interest Rates Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings August 19, 2024 Renaissance Technologies, the hedge fund founded by legendary mathematician and former NSA code breaker Jim Simons, recently disclosed its latest stock holdings in a 13F filing with the U.S. Securities... Via Benzinga These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond August 18, 2024 It's always a good time to invest cash in quality businesses. Via The Motley Fool 3 Fantastic Growth Stocks to Buy in August August 17, 2024 These stocks should keep up their winning ways. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session August 15, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 52 53 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.